BBNX
Beta Bionics, Inc.
NASDAQ · Healthcare · Medical - Equipment & Services · US
$16.84
+3.00%Year over year
Reported trailing growth
- Revenue
- +52.5%
- EBITDA
- +1.5%
- EBIT
- -32.8%
- EPS
- +48.9%
- Free cash flow
- +1.0%
- Operating cash flow
- +2.9%
Forward estimates
Based on analyst estimates
- Revenue
- +33.1%
- EBITDA
- -10.5%
- EPS
- -19.5%
Three-year CAGR
- Revenue
- +724.3%
- EBITDA
- -34.0%
- EBIT
- -58.4%
- Net income
- -33.7%
- EPS
- -41.4%
- Free cash flow
- -8.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026